MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) has reached a significant milestone with the completion and delivery of its first Edge AI Intoxication and Fatigue Detection Kiosk prototypes. These kiosks leverage artificial intelligence to analyze short voice samples for over 140 acoustic markers associated with potential alcohol, drug, or fatigue-related impairment. The AI models are trained on more than 50 million data points, enabling high accuracy in predicting intoxication. The prototypes are now entering testing, validation, and data-analysis phases involving industry participants, speech specialists, and software engineers as the company works to refine its predictive models and assess real-world performance.
The importance of this development lies in its potential to transform workplace safety across safety-sensitive industries such as mining, aviation, construction, transportation, and law enforcement. Conventional impairment detection methods like breath, saliva, urine, and laboratory testing can be costly, time-consuming, and invasive. MindBio's approach offers a rapid, scalable, and less invasive initial screening alternative. Individuals flagged for potential impairment can then undergo additional evaluation using established testing protocols, ensuring a comprehensive safety solution.
MindBio's Edge AI kiosks integrate bespoke hardware and software for voice-based detection, making them suitable for enterprise environments. The company's AI prediction model has demonstrated remarkable accuracy in predicting alcohol intoxication using only the human voice. This technology addresses the operational risks and large workforce challenges faced by industries where impairment screening is critical. By providing real-time, non-invasive testing, MindBio aims to reduce costs and improve efficiency in safety protocols.
For more information about MindBio Therapeutics and its technology, visit the company's website at www.MindBioTherapeutics.com. The latest news and updates relating to MBQIF are available in the company's newsroom at https://ibn.fm/MBQIF.
